Originally published by Robert Kraft.
Fierce Pharma Manufacturing reports that the Food and Drug Administration issued a warning letter to Ipca Laboratories concerning its API plant in Ratlam, India and two formulation facilities. Fierce Pharma Marketing says the letter describes how “employees regularly deleted failed testing data from computers and overwrote them with data that indicated APIs and products met standards.”
From the American Association for Justice news release.
Curated by Texas Bar Today. Follow us on Twitter @texasbartoday.
from Texas Bar Today http://ift.tt/1UpHlXm
via Abogado Aly Website
No comments:
Post a Comment